All Updates

All Updates

icon
Filter
Funding
Prolific Machines raises USD 55 million in Series B funding to begin commercialization efforts
Cell-cultured Meat
Jun 6, 2024
This week:
Partnerships
Microsoft and BlackRock partner to launch USD 30 billion AI data center investment fund
Machine Learning Infrastructure
Yesterday
Funding
Limitless Labs raises USD 3 million in pre-seed funding to develop prediction market
Web3 Ecosystem
Yesterday
Product updates
Google Cloud launches Blockchain RPC service for Web3 developers
Web3 Ecosystem
Yesterday
Product updates
Kore.ai launches GALE platform for enterprise GenAI adoption
Machine Learning Infrastructure
Yesterday
Product updates
Kore.ai launches GALE platform for enterprise GenAI adoption
Generative AI Infrastructure
Yesterday
Partnerships
Climeworks partners with Terraset to enable philanthropic support for carbon removal
Carbon Capture, Utilization & Storage (CCUS)
Sep 17, 2024
Funding
8 Rivers secures investment from JX Nippon to commercialize DAC technology
Carbon Capture, Utilization & Storage (CCUS)
Sep 17, 2024
Product updates
ProAmpac launches enhanced online pouch configurator MAKR by DASL for custom flexible packaging prototypes
Smart Packaging Tech
Sep 17, 2024
Funding
M&A
Majority stake in Bollegraaf Group acquired by Summa Equity for EUR 800 million
Waste Recovery & Management Tech
Sep 17, 2024
Partnerships
NASA awards Intuitive Machines contract for near-space network services
Space Travel and Exploration Tech
Sep 17, 2024
Cell-cultured Meat

Cell-cultured Meat

Jun 6, 2024

Prolific Machines raises USD 55 million in Series B funding to begin commercialization efforts

Funding

  • Prolific Machines, a biotechnology company specializing in photo molecular biology, has raised USD 54.6 million in series B funding led by The Ki Tua Fund. Breakthrough Energy Ventures, Mayfield, SOSV, Shorewind Capital, Darco Capital, Conti Ventures, and In-Q-Tel (IQT) participated.

  • Prolific Machines will use the funding for commercialization and customer acquisition, marking the company’s transition from proving the efficacy of its process to actively delivering it to people. 

  • Prolific Machines enable the transition from expensive and hard-to-control molecules to a more efficient and sustainable method—light. Through its bioreactors, it offers customers efficient biomanufacturing of high-value bioproducts, including nutritional proteins, antibodies for disease treatment, and cultivated meat.

Contact us

Gain access to all industry hubs, market maps, research tools, and more
Get a demo
arrow
menuarrow

By using this site, you agree to allow SPEEDA Edge and our partners to use cookies for analytics and personalization. Visit our privacy policy for more information about our data collection practices.